Technology

Seeing increasing dispersion

INDUSTRY VOICE: Big players in the healthcare sector are desperate to differentiate their approved 'checkpoint inhibitors' (a drug that unleashes an immune system attack on cancer cells) by combining their use with conventional chemotherapy or other new...

Previously owned by European private equity investor

Investing in new systems crucial

Focus on renewable energy

Tackling gender equality, hunger and education issues

Legacy technology remains primary obstacle

INDUSTRY VOICE: Despite market volatility in Q1, BB Biotech performed very well with an overall return of 8.8% in CHF. Several large biotech companies are currently trading below their fundamental value,and offer an attractive entry level for investors....

Major industry trend

Increased use of the 'digital ledger'